Edited by: Reto Crameri
Differences in the intrinsic immunogenicity and allergenicity of Bet v 1 and related food allergens revealed by site-directed mutagenesis
Version of Record online: 14 NOV 2013
© 2013 The Authors. Allergy published by John Wiley & Sons Ltd
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Volume 69, Issue 2, pages 208–215, February 2014
How to Cite
Differences in the intrinsic immunogenicity and allergenicity of Bet v 1 and related food allergens revealed by site-directed mutagenesis. Allergy 2014; 69: 208–215., , , , , , , , , , , .
Correction made on 24 January 2014, after first online publication: open access license statement amended.
- Issue online: 27 JAN 2014
- Version of Record online: 14 NOV 2013
- Manuscript Accepted: 26 SEP 2013
- Austrian Science Fund (FWF). Grant Numbers: L688, W1213
- Christian Doppler Research Association
|all12306-sup-0001-DataS1.docx||Word document||29K||Data S1. Methods and results.|
|all12306-sup-0002-FigS1.tif||image/tif||1749K||Figure S1. Aggregation behaviour analysis of Mal d 1, Cor a 1 and their mutants via HPSEC (big graphs) and DLS (small graphs).|
|all12306-sup-0003-FigS2.tif||image/tif||1738K||Figure S2. Three characteristic RBL titration curves for each of the Mal d 1 (up) and Cor a 1 (down) protein group.|
|all12306-sup-0004-FigS3.tif||image/tif||1879K||Figure S3. Chronology of peptide cluster formation during in vitro endolysosomal degradation.|
|all12306-sup-0005-FigS4.tif||image/tif||2534K||Figure S4. ELISPOT analysis of splenocytes from immunized mice expressed as the mean of cytokine-secreting cells per 2 × 105 cells ± SEM.|
|all12306-sup-0005-FigS5.eps||image/eps||1240K||Figure S5. IgG1 antibody responses at day 28 analysed by ELISA.|
|all12306-sup-0006-TableS1.docx||Word document||12K||Table S1. List of primers used for the construction of the Mal d 1 and Cor a 1 structural variants.|
|all12306-sup-0007-TableS2.docx||Word document||36K||Table S2. Patients' sera used within this study.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.